Cultural
-
AdvantageClub.ai raises $4 Million from Axilor Ventures to expand in the US and Asia and add New Product LinesDetails
MANILA,Philippines,Dec. 2,2024-- AdvantageClub.ai,a leader in employee engagement solutions,has raised $4 million in its latest funding round,bringing its total funding to $11 million. The round was l
-
Hong Kong Airlines Resumes Vancouver Service Offering Twice-weekly direct flights from 18 January 2025Details
HONG KONG,Dec. 2,2024-- Hong Kong Airlines celebrated its 18th anniversary on 28 November and announced the resumption of direct flights to Vancouver,Canada commencing 18 January 2025. The twice-weekl
-
Sustainable Energy Brand EBL to Unveil New Brand Identity and Innovative Power Solutions at CES 2025Details
SHENZHEN,China,Dec. 2,2024-- EBL,a pioneering sustainable energy brand committed to environmental protection,efficiency,and stability,is proud to announce that it will unveil its new brand image at CE
-
Hesai to Attend CES 2025, Launch Versatile New Mini 3D Lidar for Industrial and Robotic ApplicationsDetails
PALO ALTO,Calif.,Dec. 2,2024--Hesai (Nasdaq: HSAI),the global leader in lidar technology for robotics and industrial applications,autonomous driving,and ADAS,announced today that it will be exhibiting
-
Aon names Anne Corona as CEO of Enterprise Clients and Global Chief Commercial OfficerDetails
DUBLIN,Dec. 3,2024--Aon plc (NYSE: AON),a leading global professional services firm,today announces the appointment of Anne Corona as CEO of Enterprise Clients and global chief commercial officer,effe
-
Moon Creative Lab Venture Variloom™ Wins ISPO 2024 Award in Collaboration with Rip CurlDetails
Variloom3DP Filament and Print System Recognized as Part of Rip Curl\'s Mirage3DP Boardshort Innovating in Sustainable and Functional Design and Materials
-
Fangzhou Inc. Announces Inclusion of Its Shares in Hang Seng Hong Kong-Listed Biotech IndexDetails
HONG KONG,Dec. 3,2024-- Fangzhou Inc.("Fangzhou" or the "Company") (06086.HK),a leader in Internet healthcare solutions,announced today that the Company\'s Ordinary Shares,which t
-
VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Post-Operative Inflammation Following Cataract SurgeryDetails
VVN461,a non-steroidal dual JAK1/TYK2 immunomodulator,achieves primary endpoint,demonstrating statistical and clinical efficacy compared to vehicle in treatingpost-operative inflammation following cat
-
TraceLink Announces Grant Recipients Driving Impact Across the GlobeDetails
BOSTON,Dec. 3,2024-- TraceLink,the largest end-to-end digital network platform for intelligent orchestration of the supply chain,has announced the recipients of its 2024 corporate grant program. The
-
Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheterDetails
AUSTIN,Texas,Dec. 4,2024-- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David\'s Medical Center recently became the first in the nation to usean all-in-one high-density